172 related articles for article (PubMed ID: 14689466)
21. In vitro oxidative metabolism of cajaninstilbene Acid by human liver microsomes and hepatocytes: involvement of cytochrome p450 reaction phenotyping, inhibition, and induction studies.
Hua X; Peng X; Tan S; Li C; Wang W; Luo M; Fu Y; Zu Y; Smyth H
J Agric Food Chem; 2014 Oct; 62(43):10604-14. PubMed ID: 25272989
[TBL] [Abstract][Full Text] [Related]
22. Metabolism of vanoxerine, 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine, by human cytochrome P450 enzymes.
Cherstniakova SA; Bi D; Fuller DR; Mojsiak JZ; Collins JM; Cantilena LR
Drug Metab Dispos; 2001 Sep; 29(9):1216-20. PubMed ID: 11502731
[TBL] [Abstract][Full Text] [Related]
23. Differential maintenance of cytochrome P450 enzymes in cultured precision-cut human liver slices.
Renwick AB; Watts PS; Edwards RJ; Barton PT; Guyonnet I; Price RJ; Tredger JM; Pelkonen O; Boobis AR; Lake BG
Drug Metab Dispos; 2000 Oct; 28(10):1202-9. PubMed ID: 10997941
[TBL] [Abstract][Full Text] [Related]
24. Effect of methanol, ethanol, dimethyl sulfoxide, and acetonitrile on in vitro activities of cDNA-expressed human cytochromes P-450.
Busby WF; Ackermann JM; Crespi CL
Drug Metab Dispos; 1999 Feb; 27(2):246-9. PubMed ID: 9929510
[TBL] [Abstract][Full Text] [Related]
25. In vitro assessment of cytochrome P450 inhibition and induction potential of felotaxel (SHR110008).
Ding Y; Jia Y; Lu C; Liu W; Yang J; Song Y; Zhu Y; Yang L; Ding L; Wen A
Biomed Pharmacother; 2012 Jun; 66(4):318-21. PubMed ID: 22397757
[TBL] [Abstract][Full Text] [Related]
26. Cytochrome P450-mediated hepatic metabolism of new fluorescent substrates in cats and dogs.
van Beusekom CD; Schipper L; Fink-Gremmels J
J Vet Pharmacol Ther; 2010 Dec; 33(6):519-27. PubMed ID: 21062303
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of recombinant cytochrome P450 enzymes as an in vitro system for metabolic clearance predictions.
Stringer RA; Strain-Damerell C; Nicklin P; Houston JB
Drug Metab Dispos; 2009 May; 37(5):1025-34. PubMed ID: 19196847
[TBL] [Abstract][Full Text] [Related]
28. In vitro evaluation of the interaction potential of irosustat with drug-metabolizing enzymes.
Ventura V; Solà J; Peraire C; Brée F; Obach R
Drug Metab Dispos; 2012 Jul; 40(7):1268-78. PubMed ID: 22451700
[TBL] [Abstract][Full Text] [Related]
29. The metabolism of the piperazine-type phenothiazine neuroleptic perazine by the human cytochrome P-450 isoenzymes.
Wójcikowski J; Pichard-Garcia L; Maurel P; Daniel WA
Eur Neuropsychopharmacol; 2004 May; 14(3):199-208. PubMed ID: 15056479
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of time-dependent cytochrome P450 inhibition using cultured human hepatocytes.
McGinnity DF; Berry AJ; Kenny JR; Grime K; Riley RJ
Drug Metab Dispos; 2006 Aug; 34(8):1291-300. PubMed ID: 16679385
[TBL] [Abstract][Full Text] [Related]
31. Cytochrome P450 fluorometric substrates: identification of isoform-selective probes for rat CYP2D2 and human CYP3A4.
Stresser DM; Turner SD; Blanchard AP; Miller VP; Crespi CL
Drug Metab Dispos; 2002 Jul; 30(7):845-52. PubMed ID: 12065444
[TBL] [Abstract][Full Text] [Related]
32. Liver grafts preserved in Celsior solution as source of hepatocytes for drug metabolism studies: comparison with surgical liver biopsies.
Donato MT; Serralta A; Jiménez N; Pérez G; Castell JV; Mir J; Gómez-Lechón MJ
Drug Metab Dispos; 2005 Jan; 33(1):108-14. PubMed ID: 15448115
[TBL] [Abstract][Full Text] [Related]
33. Cytochrome P-450 mRNA expression in human liver and its relationship with enzyme activity.
Rodríguez-Antona C; Donato MT; Pareja E; Gómez-Lechón MJ; Castell JV
Arch Biochem Biophys; 2001 Sep; 393(2):308-15. PubMed ID: 11556818
[TBL] [Abstract][Full Text] [Related]
34. Rapid characterization of the major drug-metabolizing human hepatic cytochrome P-450 enzymes expressed in Escherichia coli.
McGinnity DF; Griffin SJ; Moody GC; Voice M; Hanlon S; Friedberg T; Riley RJ
Drug Metab Dispos; 1999 Sep; 27(9):1017-23. PubMed ID: 10460801
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of cytochrome P450 activities in human hepatocytes in vitro.
Gómez-Lechón MJ; Lahoz A; Castell JV; Donato MT
Methods Mol Biol; 2012; 806():87-97. PubMed ID: 22057447
[TBL] [Abstract][Full Text] [Related]
36. In vitro metabolism of a new oxazolidinedione hypoglycemic agent utilizing liver microsomes and recombinant human cytochrome P450 enzymes.
Agrawal AK; Hop CE; Pang J; Silva Elipe MV; Desai RC; Leung KH; Franklin RB
J Pharm Biomed Anal; 2005 Feb; 37(2):351-8. PubMed ID: 15708677
[TBL] [Abstract][Full Text] [Related]
37. Uroporphyrinogen oxidation catalyzed by human cytochromes P450.
Sinclair PR; Gorman N; Tsyrlov IB; Fuhr U; Walton HS; Sinclair JF
Drug Metab Dispos; 1998 Oct; 26(10):1019-25. PubMed ID: 9763408
[TBL] [Abstract][Full Text] [Related]
38. Metabolism-mediated drug interaction potential of HS-23, a new herbal drug for the treatment of sepsis in human hepatocytes and liver microsomes.
Jeong HU; Lee JY; Kwon SS; Kim JH; Kim YM; Hong SW; Yeon SH; Lee SM; Cho YY; Lee HS
Arch Pharm Res; 2015 Feb; 38(2):171-7. PubMed ID: 25052959
[TBL] [Abstract][Full Text] [Related]
39. Characterisation of the xenobiotic-metabolizing Cytochrome P450 expression pattern in human lung tissue by immunochemical and activity determination.
Bernauer U; Heinrich-Hirsch B; Tönnies M; Peter-Matthias W; Gundert-Remy U
Toxicol Lett; 2006 Jul; 164(3):278-88. PubMed ID: 16483733
[TBL] [Abstract][Full Text] [Related]
40. Effects of organic solvents on the activities of cytochrome P450 isoforms, UDP-dependent glucuronyl transferase, and phenol sulfotransferase in human hepatocytes.
Easterbrook J; Lu C; Sakai Y; Li AP
Drug Metab Dispos; 2001 Feb; 29(2):141-4. PubMed ID: 11159803
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
